Showing 11-16 of 16 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Targeted mRNA LNP strategies to modulate lymphocyte migration and Treg function for T1D immunotherapy | Trustees of the University of Pennsylvania | Michael Betts | Cures | 01-September-2024 to 31-August-2027 | $900.000,00 |
| Engineered Regulatory T cells for Suppression of Type 1 Diabetes | University of Pittsburgh | Alok Joglekar | Cures | 01-August-2026 to 31-July-2028 | $187.584,10 |
| Dock2-mediated T cell migration as a targetable shared mechanism in autoimmunity | University of Pittsburgh | Alok Joglekar | Cures | 01-September-2025 to 28-February-2027 | $149.999,05 |
| New approach for tolerance induction after allogeneic islets transplantation | University of Pittsburgh | Eric Lagasse | Cures | 01-September-2026 to 31-August-2027 | $249.994,05 |
| Insulin dose and vascular complications in T1D: its role beyond insulin resistance and glycemia | University of Pittsburgh | Rachel Miller | Improving Lives | 01-July-2026 to 30-June-2029 | $749.947,12 |
| Accelerating the Identification and Mitigation of Insulin Pump Risks using Artificial Intelligence | Veterans Health Foundation | Ronald Codario | Improving Lives | 01-August-2026 to 31-July-2027 | $189.038,48 |